article thumbnail

New Report Reveals Trends, Opportunities in Drug Development

PPD

As the clinical trial landscape evolves, drug developers are faced with novel challenges and changes in study recruitment, trial size and structure, and more. The adoption of new innovations, strategies and technologies offers opportunities to address persistent challenges and develop suitable approaches for the future.

article thumbnail

Increasing the probability of technical success in drug development using AI and patient heterogeneity

Predictive Oncology

By combining these two assets, this offering represents an opportunity to de-risk drug discovery and accelerate pipeline development. Complete the form below to download the white paper.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Essential Roadmap to Drug Development for Bioanalytical Success

Fierce BioTech

The Essential Roadmap to Drug Development for Bioanalytical Success Discover the 3 pillars of successful PK testing and conquer bioanalytical challenges with this whitepaper’s insights. Download now.

article thumbnail

Survey Uncovers Global Challenges and Opportunities in Drug Development

PPD

The PPD clinical research business of Thermo Fisher Scientific has surveyed more than 150 drug developers around the globe to gather annual data on trends in pharmaceutical research and development. Applying artificial intelligence (AI) to drug development (e.g., mRNA, drug discovery platforms) ranked as the No.

article thumbnail

How next-generation phage display libraries are accelerating antibody developability

Fierce BioTech

How next-generation phage display libraries are accelerating antibody developability Download now to learn how a next-generation phage library is overcoming the limitations of traditional antibody discovery platforms, enhancing the discovery of highly specific and effective antibody-based therapies.

article thumbnail

Advancements in CRISPR-Cas9 Gene Editing for Cardiovascular Disorders

Fierce BioTech

Advancements in CRISPR-Cas9 Gene Editing for Cardiovascular Disorders Download this whitepaper to dive into recent developments surrounding CRISPR-Cas9 gene editing technology, particularly concerning its use versus other gene-editing technologies. It also discussed its potential applications in vitro and in vivo drug development.

article thumbnail

Heterogeneous and curated biobank of live-cell tumor samples retains highly reproducible drug response data for drug and biomarker discovery

Predictive Oncology

The ability to introduce patient heterogeneity in the discovery and development stages increases the Probability of Technical Success (PTS) and reduces the risk inherent in all aspects of the drug development pipeline. Complete the form below to download the white paper.

Drugs 52